Talent pool - France
Ascendis Pharma
This listing was originally posted on Ascendis Pharma's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moAscendis Pharma is a global biopharmaceutical company committed to making a meaningful difference in patients’ lives. Guided by our core values of Patients, Science, and Passion, we are applying our innovative TransCon® technology platform to fulfill our mission of developing new therapies that demonstrate best-in-class potential to address unmet medical needs.
At our headquarters in Hellerup, Denmark, research facilities in Heidelberg, Germany, and additional offices across Europe and the United States, we are advancing programs in our Endocrinology Rare Disease and Oncology portfolios. We also collaborate with partners on the development of TransCon-based products in other therapeutic areas and markets.
Are you unable to find a relevant position among our published jobs but still interested in working at Ascendis Pharma? We are always looking for talented individuals to join our growing company. Please join our talent pool, and we will keep your resume for future opportunities.
Ascendis Pharma offers positions in various areas such as Research & Product Development, Commercial, GCP & GVP, Medical- and Regulatory Affairs, HR, Finance & IR, Communications, and IT, among others.
Please select your preferred department(s) in the application form.
Your resume must be submitted in English and is treated confidentially
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Ascendis Pharma?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Prodrug therapies
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo